-Alan D Levine Researcher Activity Profile

Research Author Detailed Information 

Alan D Levine Publication Rate By Year

Alan D Levine has published 5 paper(s) in 2007, 3 paper(s) in 2008, for a total of 8 research publications in total.

Alan D Ad Levine Author Information

LAST NAME: levine

FIRST NAME: Alan D

INITIALS: ad

AFFILIATION:

Papers

Alan D Levine's Publication Record

1. Cytokines in chronically critically ill patients after activity and rest. Year Published: 2007
Frances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland, Ohio 44118-3601, USA. chris.winkelman@case.edu
2. Angiogenesis blockade as a new therapeutic approach to experimental colitis. Year Published: 2007
Division of Gastroenterology, Istituto Clinico Humanitas, Rozzano, Milan 20089, Italy. sdanese@hotmail.com
3. Maturation of the mucosal immune system underlies colitis susceptibility in interleukin-10-deficient (IL-10-/-) mice. Year Published: 2007
Departments of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106-4952, USA.
4. Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease. Year Published: 2007
Division of Pediatric Gastroenterology and Nutrition, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.
5. Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease. Year Published: 2007
Division of Pediatric Gastroenterology and Nutrition, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.
6. TGF-{beta} Inhibits IL-2 Production and Promotes Cell Cycle Arrest in TCR-Activated Effector/Memory T Cells in the Presence of Sustained TCR Signal Transduction. Year Published: 2008
Department of Medicine and.
7. Batch test assessment of waste-to-energy combustion residues impacts on precipitate formation in landfill leachate collection systems. Year Published: 2008
Arcadis U.S., Inc., Tampa, FL 33637, USA. Antonio.Cardoso@arcadis-us.com
8. TGF-beta inhibits IL-2 production and promotes cell cycle arrest in TCR-activated effector/memory T cells in the presence of sustained TCR signal transduction. Year Published: 2008
Department of Medicine, School of Medicine, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA.